Home
AJANTPHARM.NS

Ajanta Pharma Limited

NSEHealthcare
₹3,321.30
-0.72%-₹24.00 today
₹0.00₹0.00
Ask Warren
Open
₹0.00
Prev close
₹3,345.30
Day range
₹0 – ₹0
52W range
₹2,329.9 – ₹3,506.9
Volume
83.9K
Avg vol (20D)
1.6L
Mkt cap
₹41,557.34Cr
P/E TTM
39.3×

Trade Ajanta Pharma Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Company Metrics

Revenue (ttm)₹5452.86 Cr
Net Income (ttm)₹0.00
Shares Out12.49 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.18

About AJANTPHARM.NS

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, eye drops, dry powder suspension, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, gynaecology, nephrology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees0
Stock ExchangeNSE
Ticker SymbolAJANTPHARM.NS
AJANTPHARM.NS · NSE
Financial Performance

In 2026, Ajanta Pharma Limited's revenue was ₹5452.86 Cr, an increase of +21.50% compared to the previous year. Earnings were ₹0.00, an increase of +18.60%.

Revenue (2026)
₹5452.86 Cr
+21.50% YoY
Earnings (2026)
₹0.00
+18.60% YoY
Year-over-Year Growth
Revenue
+21.50%
Earnings
+18.60%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.